<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2022</volume><submitter>Luo Y</submitter><pubmed_abstract>&lt;h4>Purpose&lt;/h4>We previously reported that G protein-coupled receptor kinase (GRK) 4 halts cell cycle progression and induces cellular senescence in HEK293 cells. The present study was aimed at assessing the prognostic value of GRK4 in hepatocellular carcinoma (HCC).&lt;h4>Methods&lt;/h4>GRK4 expression was detected by immunohistochemistry in paired tumoral and peritumoral tissues of 325 HCC patients. One hundred and twenty-six patients from Western China were utilized as a training cohort to develop a nomogram, while 86 patients from Eastern China were used as a validation cohort. The proliferation and migration of lentiviral-GRK4 expressing HepG2 cells were determined by MTT and wound healing assays.&lt;h4>Results&lt;/h4>GRK4 was differentially expressed in HCC tissues. Tumoral GRK4 intensity, tumo</pubmed_abstract><journal>Disease markers</journal><pagination>2628879</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9236775</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>G Protein-Coupled Receptor Kinase 4 Is a Novel Prognostic Factor in Hepatocellular Carcinoma.</pubmed_title><pmcid>PMC9236775</pmcid><pubmed_authors>Jiang X</pubmed_authors><pubmed_authors>Luo Y</pubmed_authors><pubmed_authors>Li R</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Xiao S</pubmed_authors></additional><is_claimable>false</is_claimable><name>G Protein-Coupled Receptor Kinase 4 Is a Novel Prognostic Factor in Hepatocellular Carcinoma.</name><description>&lt;h4>Purpose&lt;/h4>We previously reported that G protein-coupled receptor kinase (GRK) 4 halts cell cycle progression and induces cellular senescence in HEK293 cells. The present study was aimed at assessing the prognostic value of GRK4 in hepatocellular carcinoma (HCC).&lt;h4>Methods&lt;/h4>GRK4 expression was detected by immunohistochemistry in paired tumoral and peritumoral tissues of 325 HCC patients. One hundred and twenty-six patients from Western China were utilized as a training cohort to develop a nomogram, while 86 patients from Eastern China were used as a validation cohort. The proliferation and migration of lentiviral-GRK4 expressing HepG2 cells were determined by MTT and wound healing assays.&lt;h4>Results&lt;/h4>GRK4 was differentially expressed in HCC tissues. Tumoral GRK4 intensity, tumo</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-21T14:20:52.408Z</modification><creation>2025-04-21T14:20:52.408Z</creation></dates><accession>S-EPMC9236775</accession><cross_references><pubmed>35769816</pubmed><doi>10.1155/2022/2628879</doi></cross_references></HashMap>